首頁 > 市場調查報告書 > 醫療設備

生技設備

miRNA工具及服務市場規模、佔有率、成長分析（依產品類型、技術、應用、最終用戶及地區分類）－2025-2032年產業預測

市場調查報告書

商品編碼

1859400

miRNA工具及服務市場規模、佔有率、成長分析（依產品類型、技術、應用、最終用戶及地區分類）－2025-2032年產業預測

MiRNA Tools and Services Market Size, Share, and Growth Analysis, By Product Type (miRNA Expression Analysis, miRNA Isolation and Purification), By Technology, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年10月27日 | 出版商:

SkyQuest | 英文 181 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球 miRNA 工具和服務市場規模預計在 2023 年達到 3.721 億美元，從 2024 年的 4.1898 億美元成長到 2032 年的 10.8269 億美元，在預測期（2025-2032 年）內複合年成長率為 12.6%。

全球miRNA工具和服務市場正經歷強勁成長，這主要得益於慢性病和遺傳性疾病盛行率的上升，以及製藥和生技產業研發投入的增加。政府的利好政策和分子生物學技術的進步正在提高這些工具和服務的準確性和可負擔性。受託研究機構的蓬勃發展為最佳化成本和克服技術難題提供了契機。生命科學領域的合作舉措和數據共用也促進了這些工具的普及。此外，人們逐漸認知到miRNA在農業和獸醫學領域的重要性，這正在擴大其應用範圍。人工智慧、機器學習、物聯網、擴增實境和虛擬實境技術的融合，透過改進數據分析、監管合規以及教育培訓，正在革新整個市場。

推動全球miRNA工具與服務市場發展的因素

全球miRNA工具和服務市場的主要促進因素之一是慢性疾病的日益普遍，這推動了個人化醫療的研究與發展。 miRNA在基因表現和調控中發揮關鍵作用，因此對其進行分析和鑑定對於闡明疾病機制和開發標靶治療至關重要。對先進診斷工具和治療方案日益成長的需求正在推動miRNA研究領域的投資，進而促進技術創新和miRNA工具及服務的擴展。因此，這一趨勢正在促進學術機構、生技公司和製藥公司之間的合作，進而提升市場潛力。

限制全球miRNA工具與服務市場的因素

全球miRNA工具和服務市場的主要限制因素之一是先進定序技術和miRNA分析所需專用設備的高成本。這些成本對中小型實驗室和研究機構構成障礙，限制了它們投資先進miRNA工具和服務的能力。此外，數據解讀的複雜性以及對分析和檢驗結果的專業人員的需求，進一步增加了部分相關人員的進入難度。這些經濟負擔可能會阻礙miRNA技術的創新和廣泛應用，最終減緩市場成長和發展。

全球miRNA工具與服務市場趨勢

全球miRNA工具和服務市場正呈現顯著成長趨勢，其在診斷應用的應用日益廣泛，尤其是在心血管疾病、神經系統疾病和感染疾病。非侵入性診斷方法的興起推動了對miRNA工具和服務精準性的需求。同時，各國政府加強加強醫療基礎建設，並提供miRNA研究的津貼和激勵措施，這些措施也促進了miRNA服務在臨床環境中更廣泛的應用和整合。技術創新、醫療需求和扶持政策的共同作用，預計將推動miRNA工具市場在診斷行業持續成長和擴張。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2024 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2024 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2022-2024年營收年比比較

主要企業簡介

Thermo Fisher Scientific, Inc.（United States）
QIAGEN NV（Netherlands）
Illumina, Inc.（United States）
Merck KGaA（Germany）
Agilent Technologies, Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Takara Bio, Inc.（Japan）
PerkinElmer, Inc.（United States）
New England Biolabs, Inc.（NEB）（United States）
NanoString Technologies, Inc.（United States）
Abcam plc（United Kingdom）
GeneCopoeia, Inc.（United States）
OriGene Technologies, Inc.（United States）
Promega Corporation（United States）
Norgen Biotek Corp.（Canada）
Integrated DNA Technologies, Inc.（IDT）（United States）
LGC Limited（United Kingdom）
Horizon Discovery Group plc（United Kingdom）
System Biosciences（SBI）（United States）
Eurofins Scientific SE（Luxembourg）

結論與建議

簡介目錄

Product Code: SQMIG35J2163

Global MiRNA Tools Services Market size was valued at USD 372.1 million in 2023 and is poised to grow from USD 418.98 million in 2024 to USD 1082.69 million by 2032, growing at a CAGR of 12.6% during the forecast period (2025-2032).

The global miRNA tools and services market is experiencing robust growth driven by the increasing incidence of chronic and genetic diseases, alongside heightened investments in research and development from pharmaceutical and biotech sectors. Favorable government policies and technological advancements in molecular biology enhance the precision and affordability of these tools and services. The proliferation of contract research organizations presents opportunities to optimize costs and navigate technical hurdles. Collaborative initiatives and data sharing in life sciences enhance the accessibility of these tools. Additionally, awareness of miRNA's significance in agriculture and veterinary sciences broadens its application. Furthermore, the integration of AI, machine learning, IoT, augmented reality, and virtual reality is revolutionizing the market by improving data analysis, regulatory compliance, and educational training.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MiRNA Tools Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MiRNA Tools Services Market Segments Analysis

Global MiRNA Tools Services Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into miRNA Expression Analysis, miRNA Isolation and Purification, miRNA Sequencing, miRNA Inhibitors and miRNA Mimics. Based on Technology, the market is segmented into Microarray, Quantitative PCR, Next-Generation Sequencing and Northern Blotting. Based on Application, the market is segmented into Research, Diagnostics, Therapeutics and Agriculture. Based on End User, the market is segmented into Academic and Research Institutions, Biotechnology Companies, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MiRNA Tools Services Market

One key market driver for the Global miRNA Tools Services Market is the increasing prevalence of chronic diseases, which has spurred research and development in personalized medicine. As miRNAs are recognized for their critical roles in gene expression and regulation, their profiling and analysis have become essential for understanding disease mechanisms and developing targeted therapies. The growing demand for advanced diagnostic tools and therapeutic solutions is prompting investments in miRNA research, which further drives innovation and expansion in miRNA tools and services. Consequently, this trend enhances the market's potential by fostering collaborations between academic institutions, biotechnology firms, and pharmaceutical companies.

Restraints in the Global MiRNA Tools Services Market

One key market restraint for the global miRNA tools services market is the high cost associated with advanced sequencing technologies and specialized equipment required for miRNA analysis. These costs can be a barrier for small and medium-sized laboratories and research institutions, limiting their ability to invest in sophisticated miRNA tools and services. Additionally, the complexity of data interpretation and the need for skilled personnel to analyze and validate results further complicate market access for some stakeholders. This financial burden may hinder innovation and wider adoption of miRNA technologies, ultimately slowing down market growth and development.

Market Trends of the Global MiRNA Tools Services Market

The Global miRNA Tools Services market is experiencing a notable trend toward increased adoption in diagnostic applications, particularly for cardiovascular diseases, neurological disorders, and infectious diseases. The shift toward non-invasive diagnostic methods is driving demand for the precise and accurate capabilities of miRNA tools and services. Alongside this, enhanced government initiatives aimed at bolstering healthcare infrastructure-coupled with grants and incentives for miRNA research-are catalyzing a broader acceptance and integration of these services in clinical settings. This convergence of technological innovation, healthcare demand, and supportive policies positions the miRNA tools market for sustained growth and expansion in the diagnostics landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global MiRNA Tools Services Market Size by Product Type & CAGR (2025-2032)

Market Overview
miRNA Expression Analysis
miRNA Isolation and Purification
miRNA Sequencing
miRNA Inhibitors
miRNA Mimics

Global MiRNA Tools Services Market Size by Technology & CAGR (2025-2032)

Market Overview
Microarray
Quantitative PCR
Next-Generation Sequencing
Northern Blotting

Global MiRNA Tools Services Market Size by Application & CAGR (2025-2032)

Market Overview
Research
Diagnostics
Therapeutics
Agriculture

Global MiRNA Tools Services Market Size by End User & CAGR (2025-2032)

Market Overview
Academic and Research Institutions
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations

Global MiRNA Tools Services Market Size & CAGR (2025-2032)

North America (Product Type, Technology, Application, End User)
- US
- Canada
Europe (Product Type, Technology, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Technology, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Technology, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Technology, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Thermo Fisher Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio, Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs, Inc. (NEB) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCopoeia, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Norgen Biotek Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies, Inc. (IDT) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horizon Discovery Group plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
System Biosciences (SBI) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments